--- title: "Sinopharm Accord's Wind ESG rating has been upgraded to A, with a comprehensive score of 7.18, leading the ratings in the healthcare providers and services industry" type: "News" locale: "en" url: "https://longbridge.com/en/news/289164140.md" description: "On June 6, 2026, Sinopharm Accord's Wind ESG rating was upgraded from BBB to A, with a comprehensive score of 7.18, higher than the industry average. It ranks in the top 28.45% of the healthcare industry. The environmental dimension showed significant improvement, with waste management being well-established; the governance dimension also saw some enhancement; the social dimension experienced a slight decline. The company has established systematic mechanisms for employee training, occupational health, and product quality, but there is still room for improvement in the disclosure of waste recycling data" datetime: "2026-06-09T09:15:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289164140.md) - [en](https://longbridge.com/en/news/289164140.md) - [zh-HK](https://longbridge.com/zh-HK/news/289164140.md) generator: "portal-rs" --- # Sinopharm Accord's Wind ESG rating has been upgraded to A, with a comprehensive score of 7.18, leading the ratings in the healthcare providers and services industry According to Tongbi Finance, on June 6, 2026, Sinopharm Group Co., Ltd. (stock abbreviation: Sinopharm Accord, code: 000028.SZ) had its Wind ESG rating upgraded from BBB to A. The company's overall score is 7.18, higher than the healthcare providers and services industry average of 6.23. It ranks 33rd among 116 companies in the healthcare providers and services industry, placing it in the top 28.45% of the industry. The scores for the environmental, social, and governance dimensions are 5.81, 5.86, and 6.27, respectively. Compared to the previous rating, the overall score increased from 6.97 to 7.18, an improvement of 0.21 points. The contribution from management practices rose from 4.02 to 4.18, an increase of 0.16 points. The contribution from controversy events remained stable at 3.00. By dimension, the environmental score increased by 1.34 points, the social score decreased by 0.12 points, and the governance score increased by 0.89 points. ## Rating Observation In the environmental dimension, the company has demonstrated a relatively complete management and practice chain in waste management. The company promotes its subsidiaries to establish hazardous waste management systems, clarifying responsibilities for environmental risk assessment and hidden danger investigation and management, implementing full-process control, and uniformly entrusting qualified third-party organizations for transportation and compliant disposal. In 2025, the total amount of non-hazardous waste generated by the company was 240 tons, with 0.3269 tons of non-hazardous waste generated per 100 million in revenue; the total amount of hazardous waste was 45.489 tons, with 0.062 tons of hazardous waste generated per 100 million in revenue. Additionally, the company has reduced the use of consumables such as cardboard boxes and sealing tape by introducing external reusable turnover boxes to replace disposable packaging, thereby decreasing waste generation in warehousing and transportation. By the end of 2025, several subsidiaries of the company had obtained environmental management system certification. Nevertheless, there is still room for improvement in the disclosure of performance data regarding the total amount and proportion of waste recycling. In the social dimension, the company has formed a relatively systematic management and practice mechanism in employee development and training, occupational health and safety production, and product quality management. In terms of employee development, the company revised its training management system and provided dual-channel career development paths. In 2025, the total training hours for employees reached 200,633 hours, with an average training duration of 7.04 hours per person, achieving a training coverage rate of 100%. In the field of occupational health and safety production, the company obtained ISO 45001 occupational health and safety management system certification and developed a "Three-Year Action Plan for Fundamental Safety Production Improvement," organizing 476 safety training sessions, also achieving a coverage rate of 100%. In product quality management, the company relies on GSP and ISO 9001 systems to build a quality information management system covering the entire process of pharmaceuticals and medical devices, achieving dynamic monitoring and full-process traceability, with a product recall rate of only 0.05%. However, the disclosure of high-level results in research and innovation is relatively limited, and the completeness of information on topics such as medical quality and drug vigilance still needs to be strengthened In terms of governance, the company demonstrates a strong structural checks and balances mechanism and attention to ESG governance. The board of directors consists of 9 members, with an independent director ratio of 44.44%, and female directors accounting for 11.11%, with a member attendance rate of 100%. The company has established a strategic committee responsible for tracking ESG development trends, reviewing relevant policies and annual reports, and supervising policy implementation, forming an ESG governance structure that encompasses decision-making, management, and execution at three levels. In addition, the company organizes at least one ESG-specific training session for directors each year to enhance the sustainable development management capabilities of board members. However, the proportion of female executives is 0%, indicating room for improvement in gender diversity, and some ESG governance measures, such as the linkage of executive compensation to ESG performance, have not yet been disclosed. Content generated by AI on June 6, 2026, please verify important information ### Related Stocks - [000028.CN](https://longbridge.com/en/quote/000028.CN.md) - [200028.CN](https://longbridge.com/en/quote/200028.CN.md) ## Related News & Research - [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md) - [16:30 ETApollo Hospitals lanza 'Siempre Abiertos. Siempre Aquí', un hito mundial en el sector sanitario de India](https://longbridge.com/en/news/296533948.md) - [BLS data shows fastest-growing jobs through 2034 led by clean energy, healthcare, and tech](https://longbridge.com/en/news/296263775.md) - [Visa, Lockheed Martin And A Health Care Stock On CNBC’s ‘Final Trades’](https://longbridge.com/en/news/296127265.md) - [Best Buy certifies 29 supply chain facilities as zero waste under TRUE standards](https://longbridge.com/en/news/296365264.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**